Market Highlights

• Spark Therapeutics announced it will lay off more than half of its Philadelphia workforce, cutting nearly 300 employees.
• Fore Biotherapeutics, a company developing cancer treatments, has raised $38.0 million to support an international clinical trial of its drug plixorafenib in different groups of cancer patients.
• Governor Josh Shapiro announced a $30.0 million state investment to help prepare 54 acres at the Philadelphia Navy Yard for life sciences development.

Read the full report